Home Online Features Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors
Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors
Press Releases
Keymed Biosciences  
April 26, 2025

Keymed Biosciences Announces Approval of IND for CM518D1 by the National Medical Products Administration of China for the Treatment of Solid Tumors

CHENGDU, China, April 25, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced CM518D1, a CDH17-targeted antibody-drug conjugate (ADC) developed by Keymed, received Investigational New

The Bradford Era

Local & Social
Latest news for you
ePaper
google_play
app_store
This Week's Ads
Current e-Edition
ePaper
google_play
app_store
Already a subscriber? Click the image to view the latest e-edition.
Don't have a subscription? Click here to see our subscription options.
Mobile App

Download Now

The Bradford Era mobile app brings you the latest local breaking news, updates, and more. Read the Bradford Era on your mobile device just as it appears in print.

ePaper
google_play
app_store
Trending Recipes

Help Our Community

Please help local businesses by taking an online survey to help us navigate through these unprecedented times. None of the responses will be shared or used for any other purpose except to better serve our community. The survey is at: www.pulsepoll.com $1,000 is being awarded. Everyone completing the survey will be able to enter a contest to Win as our way of saying, "Thank You" for your time. Thank You!

Get in touch with The Bradford Era
Submit Content
Advertise
Subscribe
Illinois
Indiana
Iowa
Michigan
New York
Pennsylvania
© Copyright The Bradford Era 43 Main St, Bradford, PA  | Terms of Use  | Privacy Policy
Powered by TECNAVIA